Patent · US Active

15-PGDH inhibitors

US12304897B2 · kind B2 · utility

0Cited by
3References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 29, 2020
Grant dateMay 20, 2025
Priority date—
Expiry dateFeb 12, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D498/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

A compound having one of formula (1), formula (2), formula (3) and formula (4) or a pharmacologically acceptable salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.